Business Wire

Biogen Appoints Jeff Capello as Executive Vice President and Chief Financial Officer

Del

Biogen (Nasdaq: BIIB) announced today the appointment of Jeffrey D. Capello as Executive Vice President and Chief Financial Officer effective as of December 11, 2017.

Mr. Capello will lead Biogen’s Business Planning, Tax, Treasury, Internal Audit, Accounting, and Investor Relations functions. He will report to Michel Vounatsos, CEO of Biogen, will be a member of the Executive Committee, and will be based in Cambridge, Mass.

Mr. Capello brings 26 years of experience in finance. Most recently he was Executive Vice President and Chief Financial Officer of Beacon Health Options Inc. His previous experience includes founding and running his own company, Monomy Advisors, and serving as Chief Financial Officer of Ortho Clinical Diagnostics, Boston Scientific Corporation, and Perkin Elmer. Earlier in his career he was also a partner in the Boston and Amsterdam offices of PwC.

Mr. Capello is a certified public accountant. He holds a B.S. in Business Administration from the University of Vermont and an M.B.A. in Accounting from Harvard Business School. Drafted by the Buffalo Sabres in the National Hockey League, Mr. Capello played two seasons for their American Hockey League club.

“I am very excited to join Biogen, a company which is recognized as a pioneer and a leader in treating neurological diseases,” said Mr. Capello. “I look forward to working with colleagues around the world in our mission to make a difference in the lives of patients.”

“We are fortunate to have Jeff join Biogen given the depth and breadth of his experience,” said Mr. Vounatsos. “He comes to Biogen at an exciting time as we execute our business strategy, pursue business development opportunities and build our pipeline.”

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases. Founded in 1978 as one of the world’s first global biotechnology companies by Charles Weissman, Heinz Schaller, Kenneth Murray and Nobel Prize winners Walter Gilbert and Phillip Sharp, Biogen has the leading portfolio of medicines to treat multiple sclerosis; has introduced the first and only approved treatment for spinal muscular atrophy; and is focused on advancing neuroscience research programs in Alzheimer’s disease and dementia, neuroimmunology, movement disorders, neuromuscular disorders, pain, ophthalmology, neuropsychiatry, and acute neurology. Biogen also manufactures and commercializes biosimilars of advanced biologics. We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

Biogen Safe Harbor
This press release contains forward-looking statements, made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements relating to our business activities, our strategy and plans, the potential of our commercial business and pipeline programs, and the expected benefits from Mr. Capello’s appointment as Executive Vice President and Chief Financial Officer. These forward-looking statements may be accompanied by words such as “aim,” “anticipate,” “believe,” “could,” “estimate,” “except,” “forecast,” “intend,” “may,” “plan,” “potential,” “possible,” “will,” and other words and terms of similar meaning. You should not place undue reliance on these statements.

These statements involve risks and uncertainties that could cause actual results to differ materially from those reflected in such statements, including, without limitation: risks relating to management and key personnel changes; failure to compete effectively; difficulties in obtaining and maintaining adequate coverage, pricing, and reimbursement for our products; potential future healthcare reforms; the occurrence of adverse safety events; failure to protect and enforce our data, intellectual property, and other proprietary rights and uncertainties relating to intellectual property claims and challenges; uncertainty of success in developing, licensing, or acquiring other product candidates or additional indications for existing products; delay in approval of our drug candidates; product liability claims; and third party collaboration risks. The foregoing sets forth many, but not all, of the factors that could cause actual results to differ from our expectations in any forward-looking statement. Investors should consider this cautionary statement, as well as the risk factors identified in our most recent annual or quarterly report and in other reports we have filed with the U.S. Securities and Exchange Commission. These statements are based on our current beliefs and expectations and speak only as of the date of this press release. We do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Contact information

Biogen
MEDIA CONTACT:
Matt Fearer, +1 781-464-3260
public.affairs@biogen.com
or
INVESTOR CONTACT:
Matt Calistri, +1 781-464-2442
IR@biogen.com

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

BCW Names Jillian Janaczek New York Market Leader19.9.2018 15:50Pressemelding

BCW (Burson Cohn & Wolfe), a leading global communications agency, today announced Jillian Janaczek has been named Executive Vice President, Managing Director, Market Leader for New York, the firm’s largest market globally. In her new role, she will manage talent and operations of the firm’s headquarters office, maintain key client relationships and help drive business growth across all industry sectors. Rachi Govil will assume the role of Executive Vice President, Managing Director, New York Healthcare Practice Leader. “Jillian is a veteran communications professional and leader with deep experience running and growing multimillion dollar clients and large teams,” said Chris Foster, President, North America, BCW, to whom Janaczek will report. “She is also deeply committed to finding and nurturing the best talent in the business. Jillian will be an invaluable partner to me and to our entire organization as she builds the business in our largest market.” Before this role, Janaczek spent

District Court in Rotterdam (Netherlands), Accepts Jurisdiction in Securities Fraud Litigation against Petrobras19.9.2018 15:11Pressemelding

On January 23, 2017, Stichting Petrobras Compensation Foundation (the “Foundation”) initiated an international collective action for Petrobras investors who purchased Petrobras securities outside of the United States and have suffered damages as a consequence of fraud that was uncovered by the “Lavo Jato” or “Operation Car Wash” investigations at the Brazilian petrochemical company that was once the 5th largest company in the world. Petrobras has structured a significant part of its assets through the Netherlands and one of the entities issuing Petrobras securities (Petrobras Global Finance B.V.) is based in Rotterdam, the Netherlands. Moreover Petrobras is benefiting from the Dutch tax environment and Dutch investment protection treaties. Despite its strong nexus with the Dutch jurisdiction, Petrobras strongly contested the jurisdiction of the District Court in Rotterdam. Today the District Court in Rotterdam ruled in favor of the Foundation by accepting jurisdiction. Also the Court r

TRAXENS Digital Freight Train Honored as « Coup De Cœur » By ERCI Innovation Awards IoT Based Solution Presented At InnoTrans 201819.9.2018 14:00Pressemelding

TRAXENS today announced that ERCI Eurail Clusters has named TRAXENS DIGITAL FREIGHT TRAIN, Europe's first Freight Train to use an innovative IoT-based system allowing digitalization of operations, the winner of their « Coup de Cœur » Innovation Award. The prize has been given to the company at the InnoTrans 2018 tradeshow in Berlin. Initially launched with Fret SNCF, the TRAXENS DIGITAL FREIGHT TRAIN solution is based on smart devices capable of communicating with each other using wireless digital network. TRAXENS solution goes beyond smart wagons to connect the entire train offering new high-value-added services. Inherited from the Shipping Industry, TRAXENS DIGITAL FREIGHT TRAIN has been designed to work worldwide and manage any type of asset (e.g., Dry or Reefer container, wagon, trailer) which means that rail freight can be connected to the rest of the supplier chain anywhere, to explore and leverage door-to-door multimodal applications. « This industry recognition is a major miles

WilsonHCG Recognized as a Top Global RPO Provider in HRO Today Baker's Dozen for Eighth Year in a Row19.9.2018 14:00Pressemelding

WilsonHCG, a multi-award winning global leader in innovative talent solutions, has once again been recognized in HRO Today magazine's annual RPO Baker's Dozen list. It’s the eighth year in a row the company has been honored for its exemplary partnership with its clients. WilsonHCG was one of only two providers to see an increase in client satisfaction scores. The Baker’s Dozen highlights the top recruitment process outsourcing (RPO) providers on a global level and is based solely on feedback from buyers. It’s one of the most distinguished customer satisfaction surveys in the RPO industry and service providers are rated on a variety of factors including size-of-deal, breadth of solutions, and quality of service. “We’re extremely proud to be ranked in the Baker’s Dozen for the eighth year in a row. It showcases WilsonHCG’s commitment to clients and is a testament to the effort that each and every one of our people put in on a daily basis,” says John Wilson, CEO at WilsonHCG. “We’re thank

Sharjah Announces its First Fully Integrated Investors Services Centre19.9.2018 13:36Pressemelding

In a bid to support prospective foreign investors expand their international growth ambition in the UAE, its third largest emirate, Sharjah, has announced the launch of a digitally robust business facilitation initiative, the Investors Services Centre. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180919005444/en/ General photo of Sharjah (Photo: Shurooq) The emirate’s investment and development authority, Shurooq, has partnered with Injazat Services, to develop this high-end facility to offer an exhaustive list of fully integrated business consultancy services, which will specially benefit new players on the UAE turf. The office will serve as a key access point for global business owners and investors in Sharjah, and serviced by a highly trained staff, will play an integral role in facilitating high-level and mid-level investments across a variety of sectors within the emirate. Through this service centre, investors will b

ISACA Research: Only 4 in 10 Tech Professionals Confident in Security of Their Organizations’ AI Deployments19.9.2018 13:00Pressemelding

Despite heightened interest in enterprise deployment of artificial intelligence, only 40 percent of respondents to ISACA’s second annual Digital Transformation Barometer express confidence that their organizations can accurately assess the security of systems based on AI and machine learning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180919005423/en/ ISACA's 2018 Digital Transformation Barometer looks at companies' digital transformation journeys, including the technologies with the biggest impacts and the positive effect of digitally literate leaders. (Graphic: Business Wire) This becomes especially striking given the potential for serious consequences from maliciously trained AI; survey respondents identify social engineering, manipulated media content and data poisoning as the types of malicious AI attacks that pose the greatest threat within the next five years. AI/machine learning also continued to rise toward the